Recent Updates — AWRE
Aware reported third-quarter revenue of $4.4 million, down from $5.1 million in the prior-year period, with recurring revenue growing to approximately $4.0 million from $3.6 million a year ago. Operating expenses decreased to $5.4 million from $6.4 million due to cost-reduction actions expected to generate $4.0 million in annualized savings. The company posted a net loss of $0.8 million, or $0.04 per diluted share, compared with a $1.1 million loss in the prior-year quarter. Aware ended the quarter with approximately $15.4 million in cash and no debt. The company is a global leader in biometric orchestration and identity solutions.
Aware, Inc. reported second quarter 2026 financial results with revenue declining to $3.3 million from $3.9 million in the prior-year period due to lower perpetual software license sales. The company posted a net loss of $2.6 million, or $0.12 per diluted share, compared to a $1.8 million loss previously. Operating expenses rose to $6.0 million from $5.9 million, driven by 2025 hires and partially offset by spending reductions. For the first half of 2026, revenue was $6.6 million against $7.5 million year-over-year, with a net loss of $6.0 million. Management highlighted strategic advancements in its Awareness Platform, including new partnerships with ROC and Mitek and improved liveness detection capabilities. The company anticipates seasonal revenue growth in the second half of 2026 alongside lower expenses from cost-reduction actions. Aware, Inc. operates in the biometric orchestration and identity verification industry.
On July 15, 2026, Aware, Inc. appointed James Beecham, co-founder and CEO of ALTR, as a Class I Director. Additionally, at its Annual Meeting of Shareholders, the company approved an amendment to its 2023 Equity and Incentive Plan to increase the number of authorized common shares for issuance by 1,000,000 shares. Shareholders also re-elected Ajay K. Amlani and Peter R. Faubert as Class III directors, approved executive compensation on an advisory basis, and ratified RSM US LLP as the independent auditor for fiscal year 2026. The company provides biometric and health-related sensing technology.